Vegan Delta 9 gummies are edible hemp-derived THC products made without animal-based ingredients. Traditional gummies often contain gelatin, which manufacturers usually source from animal collagen. Vegan gummies replace gelatin with plant-based alternatives like pectin, a natural fiber commonly derived from fruits.

The Trump administration had an opening. The hemp market proved the concept. The polling supported the move. The fiscal argument was there. Instead, the White House published a 195-page document that reads like it was written in 1988, invokes psychosis studies with contested methodology, and affirms the recriminalization of a $28 billion industry that was, by any reasonable measure, working.

Medical marijuana is becoming increasingly mainstream across the United States, with millions of patients now using cannabis to manage conditions such as chronic pain, anxiety, PTSD, insomnia, epilepsy, and cancer-related symptoms. But as legalization expands and dispensaries become easier to access, an important issue is getting lost in the excitement: physician guidance still matters.

Start with the most obvious one. The pharmaceutical industry loses, by some estimates, around $10 billion annually in markets where medical cannabis is legal. Patients substitute cannabis for opioids, sleep aids, anti-anxiety medications, and antidepressants. Not all patients, and not always — but enough to show up in the revenue reports.

When a brand describes its CBD flower as lab tested, that phrase should carry real weight but not all testing is created equal. The gold standard is third-party testing by an ISO-certified laboratory. Third-party means the lab has no financial relationship with the brand whose products it's testing.

The 2026 awards made one thing clear: growers are done with mystery clones from anonymous sellers. Get Seeds Right Here earned #1 because it gave growers the strongest overall package: catalog, reputation, ordering experience, and a clear long-term commitment to the cannabis clone space. The rest of the top five earned their spots doing the same work at a slightly smaller scale.

Chinese researchers at Shandong University just published a study in the Journal of Archaeological Science that does something straightforward: it tells the truth about cannabis's place in human history. Using phytolith analysis — the study of microscopic plant silica structures found in soil — the team examined 132 samples from two Late Neolithic settlements in the Shandong province. What they found was not marginal or incidental. Cannabis was one of the five grains.

So, are cannabis pens gaining ground in North America? The overall trend says yes. However, a more insightful question is why they are becoming more popular and what this reveals about the future of legal cannabis.

This is the legacy knowledge drain, and it is the quiet catastrophe nobody in the cannabis industry wants to talk about openly—because acknowledging it means acknowledging that the "professionalization" of weed has, in many respects, destroyed the thing that made it worth professionalizing.

The petrochemical industry that grew in hemp's absence now generates revenues in the tens of trillions annually across its downstream product chains—plastics, synthetic fibers, lubricants, paints, solvents, packaging, insulation, construction materials.

In the rapidly evolving world of cannabis, information is the most valuable currency. For years, platforms like Cannabis.net have served as the ultimate hub for enthusiasts, patients, and industry professionals to stay informed about legalization, medical breakthroughs, and market trends

Every two years, cannabis advocates wheel out the same ritual. Ballot measures, candidate endorsements, grasstops lobbying, NORML scorecards, press releases about historic progress. Every two years, a version of the same headline runs: "Cannabis Reform Reaches Tipping Point." Every two years, the people who believed it discover that the tipping point was a marketing event.

This makes us now ponder if the future of the marijuana industry will be handed over to Big Cannabis, as this move may capitalize on a huge financial shift (possibly the biggest one we’ve ever seen): quite possibly, it could signal the end of the 280E tax laws due to Schedule III reform.

That is a fair question. The 7OH market can be confusing, especially with so many tablets, shots, gummies, powders, Pseudo products, MIT products, MGM-15 products, and specialty alkaloid blends available online. Product names can sound similar, strengths can vary widely, and shoppers need more than flashy packaging to make a confident decision.

White House Press Secretary Karoline Leavitt described the rescheduling as something the president did 'at the behest of the American public, who largely support it.' That framing deserves scrutiny. The American public largely supports full federal legalization. They were given partial medical rescheduling. These are not the same thing, and the study makes that impossible to misread.

Here is where it breaks down. Section 2 of the application — the Activity section — asks applicants to specify which substances they handle. One of those questions asks whether your firm will be handling or dispensing recreational marijuana. If you answer yes, you are, by the federal government's own definition, admitting to trafficking a Schedule I controlled substance. On a federal form. With your name, address, Social Security number, and Tax ID attached.

Minnesota's Department of Health just released the latest results of its triennial Minnesota Student Survey, and the headline reads like a prohibitionist's nightmare: there has been a 57.7 percent statewide drop in self-reported past-year cannabis use from 2013 to 2025 among 8th, 9th, and 11th graders combined. "96 percent of students report not having used cannabis in the last month," the department said in its release. Gov. Tim Walz legalized adult-use cannabis in 2023, making this the first survey cycle conducted since the state ended prohibition.

She ordered from 10 seed banks over two years. Spent $1,000 of her own money. Tracked three things — germination rates, shipping reliability, and genetics quality — and wrote it all up without monetizing a single word of it. No affiliate links buried in the copy. No sponsored sections dressed up as opinions. Just notes from someone who got tired of hitting the same recycled listicles every time she searched "best seed banks" and decided to build the resource herself.

Per the White House's own fact sheet, the executive order does several things. It directs the FDA Commissioner to issue National Priority Vouchers to psychedelic drugs that have already received Breakthrough Therapy designation, which is meant to speed up the review process.

Rescheduling cannabis to Schedule III isn’t the goal, and our work isn’t done yet. Yet, it finally cracks open a nearly ancient framework and makes way for potentially revolutionary healthcare science grounded in research while also legitimizing cannabis as medicine. We no longer have to wonder when cannabis policy will evolve; it’s now a question of when society and institutions around us will finally catch on.

Let's get one thing straight before the spin machine buries it: the federal rescheduling of cannabis from Schedule I to Schedule III did not happen because Donald Trump had a change of heart about the plant. He didn't wake up one morning with a profound respect for the 50-year fight cannabis advocates have waged against the federal government.

Based on the researchers’ findings, individuals who consumed cannabis drinks reduced alcohol intake by nearly half, and they also decreased their binge drinking tendencies. They believe that cannabis drinks have the ability to replicate alcohol’s social experience, such as being able to drink it at social events without actually drinking booze.

Here we are in 2026, and a conflict that was supposed to wrap up in six weeks is entering its seventh with no visible exit strategy. The Strait of Hormuz — through which roughly 20-21% of the world's oil flows — is now effectively a choke point in a standoff that benefits defense contractors, arms dealers, and oil speculators while regular people pay the price at the pump and at the grave.

Based on the ruling, products that are legal federally as well as at the state level can be reimbursed, which is a huge step forward, given that older policies prevented all cannabis-based substances from being reimbursed by insurance. However, we must be careful to take note of the nuances here; the ruling doesn’t treat cannabis as a primary medical treatment just yet but rather they are considered “specialized, non-primarily health-related benefits” by the Centers for Medicare and Medicaid Services (CMS).

We understand: a huge part of why people are turning to AI for medical advice is because it’s just so accessible. But more importantly, especially in the field of medical marijuana, obtaining formal medical advice can be very difficult. More than that, there is still the stigma that we have to deal with, and oftentimes, many medical marijuana patients feel dismissed by traditional healthcare.

Read it carefully and you'll find something remarkable — not alarm, not moral panic, but a measured, almost bored scientific assessment. Dr. W.W. Stockberger of the Bureau of Plant Industry told the publication there was "no reason to become excited about a sporadic outbreak of hasheesh addiction." Hemp had been growing wild across America for years. Workers labored in hemp fields their whole lives and "never became addicts." Cannabis had a "large and legitimate use in veterinary medicine." It grew wild from the Atlantic coast to the Western plains. It was, in the view of the government's own plant scientists, a weed.

There's a specific kind of credibility that only comes from the inside. When cannabis advocates say the Controlled Substances Act is a broken instrument of policy failure, it gets filed under "predictable." When a former senior DEA official writes the same thing in a peer-reviewed paper published in Science, it lands differently.

If you find this surprising, you haven't been paying close enough attention to what cannabis has always been in this country. It has never been about public health. It has never been about safety. It has been a political lever, pulled by whoever is in power, against whoever they need to target.

High-quality THCA flower represents one of the more interesting developments in the hemp space right now. For those who want a whole-plant, minimally processed cannabinoid experience, it offers real appeal.

Cannabis edibles occupy a genuinely interesting place in modern wellness culture. They offer a smoke-free, longer-lasting, and increasingly well-understood way to experience the potential benefits of cannabinoids. Whether you are drawn to CBD for its calming properties, intrigued by the gentler profile of Delta 8, or simply looking to support better sleep and recovery, edibles give you a controllable, consistent format to work with.

Advanced cannabis products give medical patients tools that simply did not exist a decade ago. From terpene-rich live resin to precise tinctures and targeted topicals, the options available today reflect a maturing industry focused on quality and patient experience.

Consistent cannabis quality is not a luxury for medical users. It is a fundamental part of getting reliable results. From accurate cannabinoid labeling to clean growing practices and proper storage, every detail in the supply chain contributes to whether a patient's experience is positive or frustrating.

In 2021, Mexico's Supreme Court declared cannabis prohibition unconstitutional, setting the stage for full legalization. Then Congress proceeded to do absolutely nothing with that ruling for years. The legislative process stalled, got punted, stalled again. So what Mexico ended up with is a patchwork legal reality where your rights exist on paper but the infrastructure to exercise them barely exists at all.

Many students, bloggers, office workers, and content writers face this same issue. Paraphrasing looks simple from the outside, but when we sit down to write, the mind sometimes gives the same sentence again and again. The good thing is that you can improve this skill fast with daily practice, clear thinking, and a simple writing method.

The United States Army just quietly removed one of its longest-standing barriers to enlistment. Recruits with a marijuana-related conviction were previously required to undergo a two-year waiting period, seek a special Pentagon waiver, and pass a drug test. Those restrictions have now been dropped for anyone with a single conviction for possessing marijuana or marijuana-related paraphernalia.

The growth medium is typically agar-based — yes, the same substance used in microbiology to grow bacterial cultures — infused with a formulation derived from something called Murashige and Skoog (MS) salts, a nutrient mixture developed in the 1960s that has become the foundation of plant tissue culture worldwide. To this base, you add specific plant hormones: cytokinins to promote shoot proliferation, auxins to promote rooting, and various other compounds depending on what growth stage you are trying to achieve.

So when the Lancet team searched databases for RCTs treating mental disorders with cannabis as the primary treatment, they found a sparse pool — and then concluded the sparse pool means cannabis doesn't work. That conclusion is circular. You can't run a rigorous trial with plant material you can barely access, in the doses people actually use, then fault the plant for the absence of results.

Nixon was a law-and-order president who weaponized federal agencies against political enemies, escalated a war he inherited, used moral panic to consolidate power, and ran a domestic drug policy built more on politics than pharmacology. He resigned in disgrace. Trump in his second term is operating in an eerily similar register. The rhetoric around drugs — fentanyl, the border, cartel activity — has been maximalist and deliberately inflammatory.

While we’re right about inflammation, we’re looking at the wrong place: the root of the problem actually lies in the fascia, not isolated in the joints or muscles. We then considered treatment options that only addressed these parts of the body, offering localized pain relief. We thought that if we stretch or knead muscles enough, and strengthen them through regular exercise, we can reduce inflammation and pain.

The New York Times flipped on cannabis last month. We covered that. Filed it, sourced it, called it what it was — institutional cowardice dressed as public health journalism. Then this week, the Wall Street Journal ran its version. AOL pushed its version. The same week. Different mastheads, same message.

There are still some major roadblocks we have to overcome, such as the federal rescheduling of cannabis, and further education of physicians and doctors in cannabinoid therapeutics. Right now, many nurses and doctors still don’t feel confident enough to discuss cannabis with patients because of the lack of training. After all, cannabis wasn’t taught in school.

The engine is Gen Z. Analytics firm Headset found that over the past year of national cannabis sales, Gen Z spent 38% of their dollars on vapor pens and only 32.5% on flower — the exact inverse of Millennials, who put 40% into flower and 25.7% into vapes. Gen Z is also the first cannabis-consuming generation to prefer the cart over everything else as their primary format.

What it became is one of the most consequential cannabis-related cases the Supreme Court has ever heard — sitting at the crossroads of the Second Amendment, federal drug law, and the legal fiction that cannabis users are inherently dangerous people who can't be trusted with firearms.

On February 9th, 2026, the New York Times editorial board published a piece titled "It's Time for America to Admit That It Has a Marijuana Problem." I read it. I read it again. I sat with my coffee and I thought: after fifty years of calling cannabis a dangerous drug, after helping architect the moral panic that sent millions of people to prison for a plant, after cheerleading a drug war that killed tens of thousands and enriched criminal organizations across two continents — the Times has decided the problem with marijuana is that people are using too much of it.

"The War on Drugs" is a 12-track musical history project chronicling America's century-long crusade against psychoactive substances — told through music, lyrics, and the kind of receipts that don't get taught in school. Each track corresponds to a specific era, a specific truth, and a specific act of institutional theater dressed up as public health policy.

Yesterday — as in literally 24 hours ago as I write this — Texas Democratic primary voters approved a ballot question asking whether the state should legalize cannabis for adults and automatically expunge criminal records for past low-level offenses. They approved it by 80% to 20%. With 92% of polling locations reporting.

This is the apocalypse we actually got — not the dramatic cinematic one with the mushroom clouds and the clear enemy and the hero's journey. The slow one. The one where the institutions keep functioning just enough to maintain plausible deniability while clearly not functioning at all. The one where you can't tell if you're witnessing the birth of tyranny or just a very bad few years. The one where the elites keep doing elite things and everyone is slowly losing their mind trying to decide how seriously to take all of it.

The enemy changes—communists, terrorists, witches, heretics, the other political party—but the mechanism remains the same. Polarization. The deliberate construction of an "us vs. them" narrative that reduces complex human beings into simplistic categories: good or evil, patriot or traitor, with us or against us. This isn't politics. This is social engineering.

A sudden, simultaneous substitution of fentanyl with nitazenes across the entire supply chain would trigger immediate pattern recognition — a spike in overdose deaths so dramatic that it would generate emergency federal response within days. The military framing would become unavoidable. The political will to respond would crystallize quickly.

Over the past few years, THCa flower has become one of the most discussed categories in cannabis. As consumers across the United States search for alternatives to traditional dispensary markets, many people are discovering that hemp-derived cannabis products have opened the door to a new kind of accessibility.